Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · IEX Real-Time Price · USD
14.28
-0.45 (-3.05%)
At close: Jul 19, 2024, 4:00 PM
14.25
-0.03 (-0.21%)
Pre-market: Jul 22, 2024, 7:38 AM EDT
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $1.30 billion as of July 22, 2024. Its market cap has decreased by -14.05% in one year.
Market Cap
1.30B
Enterprise Value
303.81M
1-Year Change
-14.05%
Ranking
Category
Stock Price
$14.28
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $1.30B, an increase of 83.42%. That is a compound annual growth rate of 10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.30B | -9.16% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
| Mar 15, 2018 | 708.10M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dynavax Technologies | 1.34B |
| Nurix Therapeutics | 1.34B |
| Phreesia | 1.32B |
| Day One Biopharmaceuticals | 1.31B |
| ANI Pharmaceuticals | 1.30B |
| Gyre Therapeutics | 1.30B |
| Immatics | 1.29B |
| Ardelyx | 1.29B |